FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain

The regulatory approval process with the U.S. Food and Drug Administration has commenced for Innocan’s LPT-CBD release technology, marking a key step in the advancement of non-opioid pain management …